Impact of Health Insurance Status on HbA1c Control Among United States Adults With Type 2 Diabetes: A Cross-Sectional Analysis of Nationally Representative Data

健康保险状况对美国2型糖尿病成人患者糖化血红蛋白(HbA1c)控制的影响:一项基于全国代表性数据的横断面分析

阅读:1

Abstract

BACKGROUND: Glycemic control is essential for reducing complications in individuals with type 2 diabetes. Health insurance is a known determinant of access to care, yet its relationship with glycemic outcomes remains underexplored in nationally representative data. Therefore, the objective of this study is to assess the association between health insurance status and glycemic control among United States (US) adults with diagnosed type 2 diabetes (diagnostic A1c cutoff ≥ 6.5%) using National Health and Nutrition Examination Survey (NHANES) data. We hypothesized that uninsured adults with type 2 diabetes would have higher odds of poor glycemic control. METHODS: A cross-sectional analysis was conducted using data from the NHANES 2013-2018 cycles. Adults aged ≥18 years with diagnosed type 2 diabetes were included. Survey-weighted logistic regression models examined the association between insurance status and poor glycemic control (glycated hemoglobin (HbA1c) ≥ 7%), adjusting for demographic, clinical, and behavioral covariates. Descriptive and inferential statistics accounted for the complex survey design. RESULTS: Among 229 million weighted US adults with diagnosed type 2 diabetes, 195,397,912 (85%) were insured. Among those with poor glycemic control, 18,684,942 (87%) were insured and 2,901,970 (13%) were uninsured. Insurance status was not significantly associated with glycemic control in either the demographically adjusted model (odds ratio (OR) = 1.15, 95% confidence interval (CI): 0.91-1.45) or the fully adjusted model (OR = 1.12, 95% CI: 0.89-1.41). Significant predictors of poor glycemic control included age, gender, body mass index (BMI), income, and race/ethnicity. CONCLUSION: Health insurance alone may not ensure optimal glycemic control. Addressing broader social and clinical factors is essential to improving outcomes in diabetes care.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。